In our first edition of ‘Cancer Dialogue’, Charles Fuchs, Global Head of Oncology & Hematology Drug Development at Roche and Genentech, sits down with Luis Paz-Ares, Head of Medical Oncology Department Hospital Universitario 12 de Octubre, at #ESMO24 to explore the biggest and most urgent challenges in oncology. Watch Luis answer and the full conversation here: http://spkl.io/6042fDQGG
Hakkımızda
Roche, insanların yaşamlarını iyileştirmek için bilimde ileri gitmeye odaklanmasıyla farmasötikte ve tanılamada küresel bir öncüdür. Farmasötik ile tanılamanın tek çatı altındaki birleşik gücü, Roche’u kişiselleştirilmiş sağlık hizmetlerinde lider yapmıştır ki - bu, her hastaya doğru tedaviyi mümkün olan en iyi şekilde uyarlamayı amaçlayan bir stratejidir. Roche; onkoloji, immünoloji, bulaşıcı hastalıklar, göz hekimliği ve merkezi sinir sistemi hastalıklarında gerçek anlamda farklılaştırılmış ilaçlarla dünyanın en büyük biyoteknoloji şirketidir. Roche aynı zamanda in vitro tanılamada ve doku esaslı kanser tanılamasında dünya lideridir ve diyabet yönetiminde ön sıralardadır. 1896’da kurulan Roche, hastalıkları önlemenin, tanılamanın ve tedavi etmenin daha iyi yollarını aramaya devam etmekte ve topluma sürdürülebilir bir katkı yapmaktadır. Şirket ayrıca tüm ilgili paydaşlarla birlikte çalışarak hastaların tıbbi yeniliklere erişimini geliştirmeyi de amaçlamaktadır. Roche tarafından geliştirilmiş olan otuz ilaç, Dünya Sağlık Örgütü Elzem İlaçlar Model Listelerine alınmıştır ki bunlar arasında hayat kurtaran antibiyotikler, sıtma ilaçları ve kanser ilaçları da vardır. Roche, Dow Jones Sürdürülebilirlik Endeksleri (DJSI) tarafından art arda dokuz yıl Farmasötik, Biyoteknoloji ve Yaşam Bilimleri Sektöründe sürdürülebilirlikte Grup Lideri olarak tanınmıştır. Genel merkezi İsviçre’nin Basel kentinde bulunan Roche Grubu, 100’den fazla ülkede faaldir ve 2017’de dünya genelinde yaklaşık 94,000 kişiyi istihdam etmiştir. Roche, 2017’de ARGE’ye 10.4 milyar İsviçre frangı yatırım yapmış ve 53.3 milyar İsviçre frangı satış beyan etmiştir. Amerika Birleşik Devletleri’nde bulunan Genentech, Roche Grubu’nun bütünüyle sahibi olduğu bir üyesidir. Roche, Japonya’daki Chugai Pharmaceutical’ın çoğunluk hisselerine sahiptir. Daha fazla bilgi için lütfen http://www.roche.com/careers sayfasına bakın. #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Web Sitesi
-
http://www.roche.com/
Roche için harici link
- Sektör
- Biyoteknoloji Araştırması
- Şirket büyüklüğü
- 10.001+ çalışan
- Genel Merkez
- Switzerland 🇨🇭
- Türü
- Halka Açık Şirket
- Uzmanlık Alanları
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data ve Science
Konum
Roche şirketindeki çalışanlar
Güncellemeler
-
Are you ready to be part of something bigger than yourself❓ Join our amazing community where your passions and talents can make a real difference. Whether it's through groundbreaking projects, meaningful connections, or unforgettable experiences, there's a place for you here. 🔍 Discover new opportunities. 🤝 Connect with like-minded individuals. 🌍 Make an impact. Don’t just watch — become a part of something greater. Your journey starts now. 🚀 Find more information about Community & Culture at Roche: https://lnkd.in/dmHgZRWQ
-
-
What sparks your interest when you think of oncology innovation and the future of cancer care? Learn from leading oncology experts as we explore some of the key developments in the space and what they may mean for cancer care in our new video series ‘Cancer Dialogue’. Stay tuned over #ESMO24 as we share the first edition of the series. What would you like to see discussed in the ‘Cancer Dialogue’ series? Comment below and have your say!
-
-
Reflecting on #ERSCongress, we are both inspired by the progress in the field and reminded of the significant burden respiratory conditions like chronic obstructive pulmonary disease (COPD) pose. Bringing together the minds behind the research and initiatives, the #ERSCongress is powering change in respiratory health. Through collaboration with leaders across the respiratory community, we can expand our understanding of complex diseases, such as #COPD and bring positive change for the millions affected. To learn more, click here: http://spkl.io/6048f8XxQ
-
-
🔬 Science has the power to transform lives, but it's the human stories that truly drive innovation. At Roche’s new pRED Innovation Center in Basel, researchers like Jens Barthold and Isabel Bachmeier are inspired by personal experiences, blending passion with cutting-edge science to solve society's toughest health challenges. Whether it’s finding a cure for Alzheimer’s or developing life-saving cancer treatments, collaboration is key. Learn how we’re breaking boundaries in healthcare—join the movement toward better solutions for patients worldwide. 🌍 Click to explore: http://spkl.io/6049f8RXF
-
🚀 For those living with #Alzheimers, we're committed to finding innovative solutions. From advancing diagnostics to pioneering new therapies, all our efforts are focused on improving the lives of people around the world. 🧠🔬 Learn more about it here: http://spkl.io/6043f8K65
-
🎉 We are excited to announce the grand opening of the Roche pRED Centre! 🎉 After more than a decade of careful planning and construction, this state-of-the-art facility is the foundation for our mission to deliver medical advances that provide more meaningful benefits to people while reducing the healthcare burden on society. Located in #Basel, a global science capital and our home base, this new research and development facility represents a significant investment in the future of healthcare innovation and our commitment to establishing Basel as a major life sciences hub. Watch the inspirational video of our new centre!
-
How to improve access and funding for cancer care in Nigeria? Learn more http://spkl.io/60474hmg9 how we transform health systems through #TogetherForChange #Partnerships #XProject
-
Chronic obstructive pulmonary disease (COPD) is currently the third leading cause of death globally, affecting 400 million, with global cases expected to rise to 600 million people by 2050. COPD is a complex and growing global health challenge, and we are committed to advancing outcomes for the many impacted by this respiratory disease. Our vision is to help those affected breathe easier. By supporting the community and investing in innovative research, we aim to make this a reality. Join us in our aim to untangle the complexities of #COPD and help address this critical health issue. To read more, click here: http://spkl.io/6044fBWd4
-
-
Roche and SAS Brasil are joining forces to provide holistic solutions and better cervical cancer outcomes for women in Brazil. Learn more http://spkl.io/6048fBdtr #TogetherForChange #Partnerships #XProject